Global miRNA Sequencing and Assay Market: Industry Analysis and Forecast (2021-2027) by Product, Technology, End-Use, and Region

Global miRNA Sequencing and Assay Market size was valued at US$ XX Mn in 2019 and the total revenue is expected to grow at 13.2% through 2019 to 2027, reaching nearly US$ XX Mn in the forecast period. The Global miRNA Sequencing and Assay Market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The Global miRNA Sequencing and Assay Market report also provides trends by market segments, Product, and investment with a competitive landscape.

Global miRNA Sequencing and Assay Market Overview.

miRNA is a family of small ribonucleic acid, with 21-25 nucleotides in a length. And this controls protein expression through transcript degradation, inhibition of translation. miRNA are now involved in the regulation of many developments and biological processes like hematopoiesis, lipid metabolism, and neuronal development.

Global miRNA Sequencing and Assay Market Dynamics:

The Global miRNA Sequencing and Assay Market was valued at USD 225.9 million in 2020 and is estimated to reach XX million with a growing CAGR of 13.2 % in the forecast period of 2019-2027. There are various benefits of miRNA like sequence independence, coverage coupled with disadvantages like high cost, infrastructure requirements, run length, and potential artifacts. The miRNA is a type of RNA sequence, uses next-generation sequencing. miRNA is different from RNA sequence and plays important role in diseases like cancer. The development in technology in nucleotide sequencing is likely to fuel the market growth in the forecast period. miRNA is a chief biomarker in various diseases like cancer, as their deregulation is responsible to cause malignancy and tumor formation. Further, increasing the application of miRNA is likely to increase the investment in the market. Moreover, the growth of the market is primarily driven by factors like advantages like miRNA sequencing over other technologies, rising research funding for genomics, and the decreasing cost of sequencing. Further, this process of RNA sequencing is highly carried out by skilled profession as this process is carried out in a highly intimate environment to avoid contamination. And lack of skilled professionals is likely to hamper the market growth in the coming future.

Global miRNA Sequencing and Assay Market Segment Analysis:

Library preparation is anticipated to adhere to the growth of the product segment of the MiRNA Sequencing and Assay Market. Library preparation is governing the growth of the product segment with the highest CAGR of 13.58% in the forecast period. The techniques like Nest-Generation Sequencing (NGS) technique for miRNA analysis is fueling the market growth in the forecast period. Moreover, Nest-Generation Sequencing (NGS) technique offers various benefits like higher sensitivity to detect low-frequency variants, the faster turnaround time for high sample volumes, comprehensive genomic coverage, the lower limit of detection, higher throughput with sample multiplexing, ability to sequencing hundreds to thousands of genes or gene regions simultaneously. Due to these benefits, the NGS technique is highly preferred in library preparation and this is estimated to motivate the growth in the forecast period. Consumables are dominating in the product segment due to the wider adoption of small RNA sequencing and the sequencing the consumables segment is marked the highest market share of 58.9% in the year 2020. Global miRNA Sequencing and Assay Market To know about the Research Methodology :- Request Free Sample Report Sequencing by Synthesis technology is supplementing the growth of the miRNA Sequencing and Assay Market. Sequencing by synthesis technology is holding a prominent market share in the miRNA Sequencing and Assay Market and accounted for the largest revenue share of 33.4% in 2020. The growth of the sequencing by synthesis technology segment is attributed to research studies carried out on sequencing of miRNA and assay by synthesis. As per the research carried out in Germany, China, the US evaluated that sequencing by synthesis (SBS) recovers more interpreted miRNA, and generated more novel miRNAs. Moreover, this technology is used in the study of several cancers. And this factor is estimated to boost the market growth in the forecast period. Research Institutes is Trending in End-User Segment of miRNA Sequencing and Assay Market. Research Institutes is dominating the end-user segment of the miRNA sequencing and assay market and the segment accounts for the largest revenue share of 56.6% in 2020. This growth is estimated due to several initiatives on research studies and the sequencing of miRNA. Moreover, the studies carried out on product development, novel drug delivery, and clinical research is boosting the market of miRNA sequencing and assay. Moreover, miRNA has various applications in cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, and various others. Further, the pharmaceutical industry is expected to grow with the highest CAGR in the forecast period. Due to rising investments in R & D and biotechnology in the development of miRNA-based therapeutics is likely to boost the market growth in the forecast period. Global miRNA Sequencing and Assay Market

Global miRNA Sequencing and Assay Market Regional Insights:

North America holds the dominating share in the market owing to the presence of prominent market players in the region like Thermo fisher scientific PerkinElmer, Inc., and others. Moreover, the investment by the government in research and development by dominating players for the innovation of advanced therapeutics, and pharmaceutical medicines is likely to fuel the market growth in the regional segment. Further, Illumina, Inc. invested USD 682 million in the R&D sector for the development of new sequence analysis technology with high-end features. Moreover, miRNA sequencing is highly used in the region and implemented by various healthcare and defense sectors like clinics, military, agriculture labs. And this adoption is stimulating the growth of the miRNA Sequencing and Assay market. The Asia Pacific is estimated to grow at a significant pace due to growing genetic research activities carried out in the region. As the region is growing with developing economies and modernization this factor is likely to motivate market growth. Moreover, China is gaining more attention in the Asia Pacific market owing to rapid advancement in technology and the chemical industry. Further, the biotechnology market of china is growing with a CAGR of 7.8% in the forecast period. Global miRNA Sequencing and Assay MarketThe objective of the report is to present a comprehensive analysis of the Global miRNA Sequencing and Assay Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global miRNA Sequencing and Assay Market dynamics, structure by analyzing the market segments and project the Global miRNA Sequencing and Assay Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global miRNA Sequencing and Assay Market make the report investor’s guide.

Global miRNA Sequencing and Assay Market Scope: Inquire before buying

Global miRNA Sequencing and Assay Market

Global miRNA Sequencing and Assay Market, by Region

• North America • Europe • Asia Pacific • The Middle East and Africa • South America

Global miRNA Sequencing and Assay Market Key Players

• Illumina Inc. • Thermo Fisher Scientific Inc. • Qiagen N.V. • Takara Bio Inc. • New England Biolabs, Inc. • Perkinelmer, Inc. • Norgen Biotek Corporation • Trilink Biotechnologies • Lexogen • Oxford Nanopore Technologies • F. Hoffmann-La Roche Ltd. • Bio-Rad Laboratories Inc. • Sigma Aldrich Corp. • HTG Molecular Diagnostics, Inc. • Rosetta Genomics Ltd. • Kaneka Corporation • Abcam PLC. • Meridian Bioscience, Inc • System Biosciences LLC
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Technology 2.3.2. Primary Research 2.3.2.1. Data from Primary Technology 2.3.2.2. Breakdown of Primary Technology 3. Executive Summary: Global miRNA Sequencing and Assay Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the MiRNA Sequencing and Assay Market 3.4. Geographical Snapshot of the MiRNA Sequencing and Assay Market, By Manufacturer share 4. Global miRNA Sequencing and Assay Market Overview, 2019-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Grades 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global miRNA Sequencing and Assay Market 5. Supply Side and Demand Side Indicators 6. Global miRNA Sequencing and Assay Market Analysis and Forecast, 2019-2027 6.1. Global miRNA Sequencing and Assay Market Size & Y-o-Y Growth Analysis. 7. Global miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 7.1. Market Size (Value) Estimates & Forecast By Product, 2019-2027 7.1.1. Library Preparation 7.1.2. Consumables 7.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 7.2.1. Sequencing By Synthesis 7.2.2. Nanopore 7.2.3. Ion Semiconductor Sequencing 7.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 7.3.1. Research Institute 7.3.2. Academia 7.3.3. CRO 8. Global miRNA Sequencing and Assay Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 9.1. Market Size (Value) Estimates & Forecast By Product, 2019-2027 9.1.1. Library Preparation 9.1.2. Consumables 9.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 9.2.1. Sequencing By Synthesis 9.2.2. Nanopore 9.2.3. Ion Semiconductor Sequencing 9.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 9.3.1. Research Institute 9.3.2. Academia 9.3.3. CRO 10. North America miRNA Sequencing and Assay Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 11.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 11.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 11.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 12. Canada miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 12.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 12.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 12.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 13. Mexico miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 13.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 13.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 13.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 14. Europe miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 14.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 14.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 14.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 15. Europe miRNA Sequencing and Assay Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 16.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 16.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 16.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 17. France miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 17.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 17.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 17.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 18. Germany miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 18.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 18.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 18.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 19. Italy miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 19.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 19.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 19.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 20. Spain miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 20.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 20.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 20.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 21. Sweden miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 21.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 21.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 21.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 22. CIS Countries miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 22.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 22.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 22.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 23. Rest of Europe miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 23.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 23.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 23.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 24. Asia Pacific miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 24.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 24.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 24.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 25. Asia Pacific miRNA Sequencing and Assay Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 26.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 26.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 26.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 27. India miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 27.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 27.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 27.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 28. Japan miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 28.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 28.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 28.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 29. South Korea miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 29.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 29.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 29.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 30. Australia miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 30.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 30.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 30.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 31. ASEAN miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 31.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 31.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 31.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 32. Rest of Asia Pacific miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 32.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 32.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 32.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 33. Middle East Africa miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 33.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 33.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 33.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 34. Middle East Africa miRNA Sequencing and Assay Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 35.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 35.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 35.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 36. GCC Countries miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 36.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 36.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 36.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 37. Egypt miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 37.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 37.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 37.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 38. Nigeria miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 38.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 38.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 38.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 39. Rest of ME&A miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 39.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 39.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 39.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 40. South America miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 40.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 40.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 40.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 41. South America miRNA Sequencing and Assay Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 42.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 42.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 42.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 43. Argentina miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 43.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 43.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 43.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 44. Rest of South America miRNA Sequencing and Assay Market Analysis and Forecasts, 2019-2027 44.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 44.2. Market Size (Value) Estimates & Forecast By Technology, 2019-2027 44.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the miRNA Sequencing and Assay Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Illumine Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Thermo Fisher Scientific Inc. 45.3.3. Qiagen N.V. 45.3.4. Takara Bio Inc. 45.3.5. New England Biolabs, Inc. 45.3.6. Perkinelmer, Inc. 45.3.7. Norgen Biotek Corporation 45.3.8. Trilink Biotechnologies 45.3.9. Lexogen 45.3.10. Oxford Nanopore Technologies 45.3.11. F. Hoffmann-La Roche Ltd. 45.3.12. Bio-Rad Laboratories Inc. 45.3.13. Sigma Aldrich Corp. 45.3.14. HTG Molecular Diagnostics, Inc. 45.3.15. Rosetta Genomics Ltd. 45.3.16. Kaneka Corporation 45.3.17. Abcam PLC. 45.3.18. Meridian Bioscience, Inc 45.3.19. System Biosciences LLC 46. Primary Key Insights

About This Report

Report ID 113541
Category Healthcare
Published Date Jul 2021
Updated Date
Contact Us